The University of California, San Diego Health Sciences and its expanding Clinical and Translational Research Institute (CTRI) have received a five-year, $37.2 million Clinical and Translational Science Award from the National Center for Research Resources (NCRR), part of the National Institutes of Health.
UC San Diego joins an elite consortium of institutions in a national network dedicated to improving biomedical research by accelerating the application of laboratory discoveries into effective treatments for patients, more actively engaging communities in clinical research, and by training future generations of varied types of clinical and translational researchers.
"Medical science is evolving and growing exponentially. The need and demand for creative research projects, programs and people who can translate this basic research into real, beneficial therapies and treatments will only increase," said David Brenner, MD, vice chancellor for health sciences and dean of the School of Medicine at UC San Diego.
"UC San Diego has a long, proven track record in translational science. From the Moores Cancer Center and the many research institutes on campus to our deep involvement in major clinical trials and status as one of the nation's top teaching hospitals, the university has established itself as a vital hub for this kind of inspired work. This grant allows us, with the CTRI leading the way, to push ahead in new and even more imaginative ways, to advance medical research further, faster."
Launched in 2006, the NCRR's Clinical and Translational Science Awards program emphasizes interdisciplinary collaboration among scientists and innovative approaches that resolve difficult medical challenges.
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis